magent
Lencioni 2010 mRECIST for typical intrahepatic HCC target lesions. First-match: PD if new_lesion or a 20% or greater viable-sum increase vs nadir; else CR if arterial enhancement disappeared in all targets; else PR if a 30% or greater viabl
Go to this service →Our latest check (2026-10-11)
- Answering
- Yes — valid x402 payment terms
- Time to answer
- 171 ms
- Price
- $0.005 per call
- Paying buyers, last 30 days
- 2 (directory's own records)
- Paid calls, last 30 days
- 3
- Category
- Events, tickets and sports
- Address
- https://api.magentlab.com/api/calc/mrecist
Accuracy: paid answers checked against an independent record
Not yet in our paid checks. A seller we have not checked has neither passed nor failed.
For agents
This page as JSON: /sellers/d66ee53a47d6.json. Paid lookup by address: GET /api/seller?resource=… ($0.001, x402).